title: Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy.
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Uccelli
authors.forename: Carlo
authors.initials: C
authors.lastname: Torti
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quiros-Roldan
authors.forename: Carmine
authors.initials: C
authors.lastname: Tinelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Patroni
authors.forename: Francesco
authors.initials: F
authors.lastname: Castelli
authors.forename: Giampiero
authors.initials: G
authors.lastname: Carosi
authors.forename: Paolo
authors.initials: P
authors.lastname: Airò
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000097:blood*
chemical_list: D015415:Biomarkers; D019253:Proto-Oncogene Proteins c-bcl-2